JPMORGAN CHASE & CO - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 70 filers reported holding VIRACTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$750
-26.3%
7210.0%0.00%
Q2 2023$1,017
+1.7%
7210.0%0.00%
Q1 2023$1,000
+99900.0%
7210.0%0.00%
Q4 2022$1
-100.0%
721
-67.9%
0.00%
Q3 2022$10,000
+66.7%
2,244
+46.8%
0.00%
Q2 2022$6,000
-94.1%
1,529
-92.9%
0.00%
Q1 2022$102,000
+61.9%
21,441
+24.4%
0.00%
Q4 2021$63,000
-98.6%
17,231
-97.0%
0.00%
-100.0%
Q3 2021$4,632,000
+2831.6%
577,677
+4050.3%
0.00%
Q2 2021$158,00013,9190.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$1,096,6370.23%
Aisling Capital Management LP 288,571$458,8280.22%
BVF INC/IL 3,614,662$5,747,3130.21%
Rubric Capital Management LP 1,487,385$2,364,9420.06%
HAMILTON LANE ADVISORS LLC 35,791$570.02%
MAI Capital Management 379,468$603,3540.01%
Laurion Capital Management LP 698,000$1,109,8200.01%
TRUST CO OF TOLEDO NA /OH/ 28,000$44,5200.01%
RP Management, LLC 3,700$5,8830.01%
Jasper Ridge Partners, L.P. 92,939$147,7730.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders